Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 382

1.

Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.

Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.

Am J Kidney Dis. 2007 Dec;50(6):908-17.

PMID:
18037091
2.

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.

PMID:
16298269
3.

Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure.

Hermida RC, Ayala DE, Calvo C.

Curr Opin Nephrol Hypertens. 2005 Sep;14(5):453-9. Review.

PMID:
16046904
4.

Nephroprotection by antihypertensive agents.

Schmieder RE.

J Cardiovasc Pharmacol. 1994;24 Suppl 2:S55-64. Review.

PMID:
7898095
5.

Antihypertensive therapy in the presence of proteinuria.

Sarafidis PA, Khosla N, Bakris GL.

Am J Kidney Dis. 2007 Jan;49(1):12-26. Review.

PMID:
17185142
6.

Renoprotective effects of antihypertensive drugs.

Preston RA.

Am J Hypertens. 1999 Jan;12(1 Pt 2):19S-32S. Review.

PMID:
10077416
7.

[Perfect 24-hr blood pressure control using self-measured blood pressure and ambulatory blood pressure monitoring in chronic kidney disease].

Kario K.

Nihon Jinzo Gakkai Shi. 2009;51(4):465-70. Review. Japanese. No abstract available.

PMID:
19601555
8.

Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.

Galceran J, Plana J, Felip A, Pou G, Vila J, Sobrino J.

Expert Rev Cardiovasc Ther. 2010 Jun;8(6):751-7. doi: 10.1586/erc.10.48. Review.

PMID:
20528630
9.
10.

A comparative review of the efficacy of antihypertensive agents on 24 h ambulatory blood pressure.

Lacourcière Y, Poirier L, Lefebvre J.

Can J Cardiol. 2000 Sep;16(9):1155-66. Review. English, French.

PMID:
11021959
11.

Ambulatory 24-hour blood pressure versus self-measured blood pressure in pharmacologic trials.

Mengden T, Weisser B, Vetter W.

J Cardiovasc Pharmacol. 1994;24 Suppl 2:S20-5. Review.

PMID:
7898091
12.

Hypertension, renal disease, and drug considerations.

Sica DA.

J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):24-30. Review.

13.

Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.

Locatelli F, Del Vecchio L, Andrulli S, Colzani S.

Kidney Int Suppl. 2002 Dec;(82):S53-60. Review.

PMID:
12410856
14.

Circadian rhythm of blood pressure and the relation to cardiovascular events.

Giles TD.

J Hypertens Suppl. 2006 Apr;24(2):S11-6. Review.

PMID:
16601555
15.
16.

[Treatment for the elderly hypertensive patient with renal insufficiency].

Kobayashi K, Kanno Y, Suzuki H.

Nihon Rinsho. 2005 Jun;63(6):1047-51. Review. Japanese.

PMID:
15948389
17.

Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension.

Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F.

Blood Press Monit. 2010 Aug;15(4):173-80. doi: 10.1097/MBP.0b013e32833c7308. Review.

PMID:
20571367
18.

Efficacy of antihypertensive drugs given once a day: the calcium antagonists revisited.

Staessen JA, Celis H, Thijs L, Fagard R, Amery AK.

J Hypertens Suppl. 1994 Nov;12(8):S107-15. Review.

PMID:
7707149
19.

Blood pressure in renal disease: how to accomplish the goal?

Robles NR, Hernandez-Gallego R.

Cardiovasc Ther. 2012 Aug;30(4):193-8. doi: 10.1111/j.1755-5922.2010.00260.x. Review.

PMID:
22759229
20.

[Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].

Jermendy G.

Orv Hetil. 2004 May 2;145(18):949-56. Review. Hungarian.

PMID:
15188641

Supplemental Content

Support Center